A detailed history of Anthracite Investment Company, Inc. transactions in Grifols Sa stock. As of the latest transaction made, Anthracite Investment Company, Inc. holds 614,554 shares of GRFS stock, worth $4.72 Million. This represents 2.42% of its overall portfolio holdings.

Number of Shares
614,554
Holding current value
$4.72 Million
% of portfolio
2.42%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$6.28 - $9.38 $3.86 Million - $5.76 Million
614,554 New
614,554 $5.46 Billion
Q1 2024

May 09, 2024

BUY
$5.47 - $11.38 $1.61 Million - $3.36 Million
294,930 New
294,930 $1.97 Billion

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.21B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Anthracite Investment Company, Inc. Portfolio

Follow Anthracite Investment Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anthracite Investment Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Anthracite Investment Company, Inc. with notifications on news.